Posts Tagged: Cell
News
In an emotion-choked session, the mother of a six-year-old girl thanked California’s stem cell agency for saving the life of her daughter. “Thank you for keeping my family complete,” said Alysia Padilla-Vaccaro, her voice cracking as she spoke to the governing board of the $3 billion California Institute for Regenerative Medicine (CIRM), as the agency is formally known.
News
After a hiccup last month, the California stem cell agency this week coughed up $15 million for a quartet of researchers looking into Alzheimer’s disease, cartilage repair, arthritis and sickle cell disease, but not before lopping off a big chunk of one proposal.
Analysis
Donald Trump’s victory last night, oddly enough, could be good news for the future of the California stem cell agency. It could be George Bush all over again.
News
The Marshall Project: Two years ago, a Belgian Malinois named Drako earned a flurry of press attention when his proud owners at the California Department of Corrections and Rehabilitation announced he had found his thousandth contraband cell phone in the state’s prisons. He’d once found thirty stashed in a microwave, and one hidden in a jar of peanut butter.
Opinion
OPINION: The conventional wisdom, promoted by some advocacy groups when it suits their purposes, is that seniors are sad, helpless creatures who prefer to sit on the couch clutching their turntables and rotary phones, in front of black and white television sets, searching for reruns of Lawrence Welk. These demeaning attitudes are far from true.
Recent News
Directors of California’s stem cell agency this morning approved financing terms for a proposed, $150 million, public-private company that the agency hopes will accelerate the creation of long-sought stem cell therapies. The plan to create a stem cell “powerhouse” is likely to be one of the landmark legacies of the state’s $3 billion research effort — for better or worse.
News
A new stem cell company that targets cancer by unleashing an “eat me” trigger has emerged from a $30 million investment by the state of California. Creation of the Palo Alto firm, which is called Forty Seven, Inc., was announced Feb. 24 by its backers and its key researcher, Irv Weissman, director of Stanford University’s stem cell program.
News
California’s stem cell agency has embarked on what is likely to be an exhaustive review of genetic alteration of human embryos with likely recommendations for changes in the $3 billion research effort. The 11-year-old agency plans to examine a host of issues ranging from inadvertent, inheritable changes in the human race to informed consent on the part of patients.
News
The $3 billion California stem cell agency next Thursday will convene a day-long examination of human gene editing, a field that could be a “gold mine for biotechnology” and perhaps alter the human race permanently. “Easy DNA Editing Will Remake the World. Buckle Up.” is the way Wired magazine put it in a headline on a lengthy overview article last July.
News
With no fanfare, California’s $3 billion stem cell agency is making a significant step forward in openness and transparency regarding the dealings of its governing board, which operates outside of the control of the governor and Legislature. Tuesday’s meeting of the directors’ Science Subcommittee will be available live for the first time — for all practical purposes — on the Internet and as an audiocast, including access to presentations that are used at the meeting.
Throat cancer patient Karl Trede, who was treated with the "eat me" protein therapy. (Photo: California Institute for Regenerative Medicine)
